DYNAMIC AI: Digital Innovation With Remote Management and Predictive Modelling to Integrate COPD Care With Artificial Intelligence-based Insights: An Acceptability, Feasibility and Safety Study
NCT05914220 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-06-22
Summary
DYNAMIC AI is an MHRA-regulated medical device trial that will examine the feasibility of using AI predictive models within COPD multi-disciplinary team meetings, to allow clinicians to prioritise and optimise COPD management.
Conditions
Interventions
- DEVICE
-
AI Insights Application
Predictive AI Model Risk score
Sponsors & Collaborators
-
Lenus Health
collaborator UNKNOWN -
University of Glasgow Robertson Centre for Bio Statistics
collaborator UNKNOWN -
NHS Greater Glasgow and Clyde
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2024-03-31
- Completion
- 2024-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01205269 ·Status: COMPLETED ·Phase: PHASE2
-
Early Screening of Young COPD and Pre-COPD
NCT06844175 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
NCT00665600 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
NCT00358436 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study
NCT01426009 ·Status: COMPLETED ·Phase: PHASE2
-
A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator
NCT01794780 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
NCT01985334 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo
NCT01005901 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01013142 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
NCT02416102 ·Status: TERMINATED ·Phase: PHASE4
-
Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients
NCT03359122 ·Status: COMPLETED
-
Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01054170 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)
NCT02497001 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02294734 ·Status: COMPLETED ·Phase: PHASE2
-
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
NCT02552160 ·Status: COMPLETED
-
Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00676052 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00422604 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Inhaled Corticoid Prescriptions in General Medicine
NCT03179826 ·Status: COMPLETED
-
A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD
NCT06619210 ·Status: COMPLETED ·Phase: PHASE2
-
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758459 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)
NCT04441788 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)
NCT01153321 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy
NCT00791518 ·Status: COMPLETED
-
A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients
NCT01498081 ·Status: COMPLETED ·Phase: PHASE2
-
IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study
NCT00883584 ·Status: UNKNOWN ·Phase: PHASE2